Objection pursuant to Rule 115(2) and (3) of the Rules of Procedure to the draft Commission Implementing Decision renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize T25 (ACS-ZMØØ3-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council

The renewal of authorization for genetically modified maize T25 is contested due to insufficient assessment of long-term risks to health and the environment. The maize is resistant to glufosinate, a herbicide banned in the EU, raising concerns about increased pesticide residues. The lack of evidence on cumulative effects contradicts the precautionary principle and the 'One Health' approach. Approval could disadvantage EU farmers by allowing imports that do not meet domestic standards. A reform of the authorization process is demanded to address democratic deficits and lack of member state support.